文献速递细菌感染、耐药与抗菌药物新发突发、热带与寄生虫病

COVID-19与抗菌药物耐药性:并行且相互作用的卫生紧急事件

Coronavirus Disease 2019 and Antimicrobial Resistance: Parallel and Interacting Health Emergencies.
PubMed 文献 · Clin Infect Dis · 2021-01-01

该文指出COVID-19大流行与抗菌药物耐药性(AMR)是并行且相互作用的卫生紧急事件,二者措施与后果可比,可相互借鉴。在缺乏特异性治疗时推动使用现有抗菌药物救治重症COVID-19患者,可能影响AMR;而防控COVID-19的措施也可能减缓AMR。理解COVID-19对AMR趋势的影响有助于规划下一步AMR应对,研究者应开始收集数据以衡量当前COVID-19政策与规划对AMR的影响。

要点

  • COVID-19与AMR是并行且相互作用的卫生紧急事件,可相互借鉴。
  • 缺乏特异性治疗时使用现有抗菌药物救治重症COVID-19患者可能影响AMR。
  • 应收集数据衡量COVID-19政策与规划对AMR的影响。

核心结论

  • COVID-19大流行与AMR是并行且相互作用的卫生紧急事件,理解前者对后者趋势的影响有助于规划AMR应对。

主要发现

  • COVID-19与AMR的措施和后果具有可比性,COVID-19大流行有助于说明AMR的潜在长期影响。
  • 在缺乏特异性治疗时推动使用现有抗菌药物治疗重症COVID-19患者,可能使二者相互影响。
  • 防控COVID-19传播的措施也可能减缓AMR。

临床怎么用

  • 研究者应开始收集数据,以衡量当前COVID-19政策与规划对AMR的影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The coronavirus disease 2019 (COVID-19) pandemic and antimicrobial resistance (AMR) are parallel and interacting health emergencies that provide the opportunity for mutual learning. As their measures and consequences are comparable, the COVID-19 pandemic helps to illustrate the potential long-term impact of AMR, which is less acute but not less crucial. They may also impact each other as there is a push to use existing antimicrobials to treat critically ill COVID-19 patients in the absence of specific treatments. Attempts to manage the spread of COVID-19 may also lead to a slowdown in AMR. Understanding how COVID-19 affects AMR trends and what we can expect if these trends remain the same or worsen will help us to plan the next steps for tackling AMR. Researchers should start collecting data to measure the impact of current COVID-19 policies and programs on AMR.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Nieuwlaat R, Mbuagbaw L, Mertz D, et al. Coronavirus Disease 2019 and Antimicrobial Resistance: Parallel and Interacting Health Emergencies. Clin Infect Dis. 2021. PMID: 32544232. doi:10.1093/cid/ciaa773

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。